SL
CL icon

Summitry LLC’s Colgate-Palmolive CL Stock Holding History

Summitry LLC’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$341K Buy
3,718
+1,272
+52% +$111K 0.01% 222
2026
Q1 		$208K Buy
+2,446
New +$218K 0.01% 276
2025
Q3 		– Sell
-4,614
Closed -$419K – 224
2025
Q2 		$419K Buy
+4,614
New +$421K 0.02% 108

Other funds holding CL

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
SP
Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
PAM
PineStone Asset Management Montreal, Quebec, Canada $16.2B AUM 25.74% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
JIC
Johnson Investment Counsel Cincinnati, Ohio $13.7B AUM 21.52% 1-Year Est. Return
WG
Welch Group Birmingham, Alabama $2.93B AUM 27.62% 1-Year Est. Return

Summitry LLC's CL Position: Q2 2026 in Review

Summitry LLC increased its Colgate-Palmolive (CL) stake by 52% in Q2 2026, buying an estimated $111K and bringing the position to 3,718 shares worth $341K. The position accounts for 0.01% of the portfolio, ranked #222.

Summitry LLC first reported a position in CL in Q2 2025 and has held it in 3 quarters since. The position peaked at $419K in Q2 2025. 597 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Summitry LLC held 3,718 shares of Colgate-Palmolive worth $341K as of Q2 2026.
  • Summitry LLC bought 1,272 Colgate-Palmolive shares in Q2 2026, an estimated $111K.
  • Colgate-Palmolive made up 0.01% of Summitry LLC's portfolio in Q2 2026, its #222 holding.
  • Summitry LLC first reported a position in Colgate-Palmolive in Q2 2025 and has held it in 3 quarters since.
  • Summitry LLC's Colgate-Palmolive position peaked at $419K in Q2 2025.
  • 597 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Summitry LLC's 13F filing for Q2 2026, filed 21 Jul 2026.